Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Multinational, Randomized, Double-blind, Controlled, Dose Comparison Study to Evaluate Safety and Efficacy of MP4OX Plus Standard Treatment, in Severely Injured Trauma Subjects With Lactic Acidosis Due to Hemorrhagic Shock

NCT01973504 is registered in ClinicalTrials.gov with Sangart as lead sponsor.

NCT NCT01973504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01973504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Multinational, Randomized, Double-blind, Controlled, Dose Comparison Study to Evaluate Safety and Efficacy of MP4OX Plus Standard Treatment, in Severely Injured Trauma Subjects With Lactic Acidosis Due to Hemorrhagic Shock
Lead sponsor
Sangart
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2013
Completion date
March 31, 2016
Enrollment
0 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic shock, lactic acidosis, trauma